Columbia Laboratories Inc. (Nasdaq: CBRX) will hold a conference call on May 9, 2013, to discuss financial results of the first quarter ended March 31, 2013. Frank Condella, President and Chief Executive Officer, and Jonathan Lloyd Jones, Vice President and Chief Financial Officer of Columbia Laboratories, will host the call.
Date: | Thursday, May 9, 2013 | ||||||||
Time: | 11:00 am Eastern Time | ||||||||
Dial-in numbers: | (877) 303-9483 (U.S. & Canada) or (760) 666-3584 | ||||||||
Conference ID: | 52824557 | ||||||||
Live webcast: | www.columbialabs.com under the 'Investors' tab | ||||||||
The teleconference replay will be available two hours after completion through Thursday, May 16, 2013, at (855) 859-2056 (U.S. & Canada) or (404) 537-3406. The conference ID for the replay is 52824557. The archived webcast will be available for one year on the Company's website, www.columbialabs.com, in the 'Investors' section under 'Events'.
About Columbia Laboratories
Columbia Laboratories, Inc. is a specialty pharmaceutical company with a successful history of developing proprietary, vaginally administered products for women’s health indications. For more information, please visit www.columbialabs.com.
Contacts:
Jonathan Lloyd Jones, 973-486-8818
Vice
President & CFO
or
The Trout Group LLC
Seth Lewis,
646-378-2952
Senior Vice President